BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34095755)

  • 1. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.
    Levi M
    Hemasphere; 2021 Jun; 5(6):e571. PubMed ID: 34095755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review.
    Robba C; Battaglini D; Ball L; Valbusa A; Porto I; Della Bona R; La Malfa G; Patroniti N; Brunetti I; Loconte M; Bassetti M; Giacobbe DR; Vena A; Silva CLM; Rocco PRM; Pelosi P
    J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33401632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy in COVID-19.
    Lio KU; Rali P
    Lung India; 2021 Mar; 38(Supplement):S53-S57. PubMed ID: 33686980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review.
    Kasinathan G; Sathar J
    Ann Med Surg (Lond); 2020 Aug; 56():173-177. PubMed ID: 32637095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.
    McGonagle D; O'Donnell JS; Sharif K; Emery P; Bridgewood C
    Lancet Rheumatol; 2020 Jul; 2(7):e437-e445. PubMed ID: 32835247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
    Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Burke J; Hua F; Apgar J; Talmor DS; Sauaia A; Liptzin DR; Veress LA; Yaffe MB
    Res Pract Thromb Haemost; 2020 May; 4(4):524-531. PubMed ID: 32542213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis and coagulopathy in COVID-19: An illustrated review.
    Levi M; Hunt BJ
    Res Pract Thromb Haemost; 2020 Jul; 4(5):744-751. PubMed ID: 32685883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis-Associated Coagulopathy.
    Scarlatescu E; Tomescu D; Arama SS
    J Crit Care Med (Targu Mures); 2016 Oct; 2(4):156-163. PubMed ID: 29967855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation, ferrotoxicity and the future of translational lung cancer research.
    Zacharski LR
    Transl Lung Cancer Res; 2016 Jun; 5(3):280-7. PubMed ID: 27413710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Related Coagulopathy: A Distinct Entity?
    Marchandot B; Sattler L; Jesel L; Matsushita K; Schini-Kerth V; Grunebaum L; Morel O
    J Clin Med; 2020 May; 9(6):. PubMed ID: 32486469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance.
    Cannegieter SC; Klok FA
    Res Pract Thromb Haemost; 2020 May; 4(4):439-445. PubMed ID: 32542209
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary intravascular coagulopathy in COVID-19 pneumonia.
    Brondani G; Apollonio L; Gremese E; Ferraccioli G
    Lancet Rheumatol; 2020 Aug; 2(8):e458. PubMed ID: 32835252
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
    Castro P; Palomo M; Moreno-Castaño AB; Fernández S; Torramadé-Moix S; Pascual G; Martinez-Sanchez J; Richardson E; Téllez A; Nicolas JM; Carreras E; Richardson PG; Badimon JJ; Escolar G; Diaz-Ricart M
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):547-560. PubMed ID: 34097193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review.
    Matli K; Farah R; Maalouf M; Chamoun N; Costanian C; Ghanem G
    Open Heart; 2021 Jun; 8(1):. PubMed ID: 34099529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets.
    Violi F; Cammisotto V; Pignatelli P
    Platelets; 2021 Nov; 32(8):1009-1017. PubMed ID: 34097572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Thrombosis and Thromboembolism in COVID-19.
    Poor HD
    Chest; 2021 Oct; 160(4):1471-1480. PubMed ID: 34153340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Bourguignon A; Arnold DM; Warkentin TE; Smith JW; Pannu T; Shrum JM; Al Maqrashi ZAA; Shroff A; Lessard MC; Blais N; Kelton JG; Nazy I
    N Engl J Med; 2021 Aug; 385(8):720-728. PubMed ID: 34107198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.
    de Bruijn S; Maes MB; De Waele L; Vanhoorelbeke K; Gadisseur A
    J Thromb Haemost; 2021 Aug; 19(8):2014-2018. PubMed ID: 34105244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets.
    Liu H; Hu T; Zhang C; Chen X; Zhang S; Li M; Jing H; Wang C; Hu T; Shi J
    Am J Transl Res; 2021; 13(5):3925-3941. PubMed ID: 34149990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.